Although numerically modest (≈ −4.7 percentage points on average), this CD4+ reduction may be biologically pertinent to T-cell balance in CLL; interpretation remains cautious given study limitations. This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.